On behalf of NCI’s Epidemiology and Genomics Research Program (EGRP), it is my pleasure to inform you that your manuscript, Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa, has been included in EGRP’s Research Highlights for 2022. In October 2022, EGRP asked NCI grantees with projects supported by current or recently closed grants (i.e., grants that ended in 2021 or 2022) that are or were managed by EGRP to nominate one publication from 2022 that exemplified the research from the grant.
top of page
Search
Recent Posts
See AllAbstract Men of African descent have the highest prostate cancer incidence and mortality rates, yet the genetic basis of prostate cancer...
830
Prostate cancer (PCa) is the most widespread solid organ malignancy in males and ranks as the fifth leading cause of death globally....
80
Executive summary Prostate cancer is the most common cancer in men in 112 countries, and accounts for 15% of cancers. In this Commission,...
510
bottom of page
Comentarios